These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 17143952)

  • 1. Safety and efficacy of hepatitis A vaccine in children with chronic liver disease.
    El-Karaksy HM; El-Hawary MI; El-Koofy NM; El-Sayed R; El-Raziky MA; Mansour SA; Taha GM; El-Mougy F
    World J Gastroenterol; 2006 Dec; 12(45):7337-40. PubMed ID: 17143952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity and safety of hepatitis A vaccine in children with chronic liver disease.
    Ferreira CT; da Silveira TR; Vieira SM; Taniguchi A; Pereira-Lima J
    J Pediatr Gastroenterol Nutr; 2003 Sep; 37(3):258-61. PubMed ID: 12960646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of hepatitis A vaccination in liver transplantation recipients.
    Arslan M; Wiesner RH; Poterucha JJ; Zein NN
    Transplantation; 2001 Jul; 72(2):272-6. PubMed ID: 11477352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Should one vaccinate patients with chronic liver disease for hepatitis A virus in India?
    Anand AC; Nagpal AK; Seth AK; Dhot PS
    J Assoc Physicians India; 2004 Oct; 52():785-7. PubMed ID: 15909855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity, safety, and interchangeability of two inactivated hepatitis A vaccines in Chilean children.
    Abarca K; Ibánez I; Perret C; Vial P; Zinsou JA
    Int J Infect Dis; 2008 May; 12(3):270-7. PubMed ID: 17988917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of immunogenicity between inactivated and live attenuated hepatitis A vaccines: a single-blind, randomized, parallel-group clinical trial among children in Xinjiang Uighur Autonomous Region, China.
    Liu XE; Wushouer F; Gou A; Kuerban M; Li X; Sun Y; Zhang J; Liu Y; Li J; Zhuang H
    Hum Vaccin Immunother; 2013 Jul; 9(7):1460-5. PubMed ID: 23571173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity and safety of a pediatric dose of a virosomal hepatitis A vaccine in healthy children in India.
    Jain H; Kumavat V; Singh T; Versteilen A; Sarnecki M
    Hum Vaccin Immunother; 2014; 10(7):2089-97. PubMed ID: 25424821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistence of hepatitis A vaccine induced seropositivity in infants and young children by maternal antibody status: 10-year follow-up.
    Sharapov UM; Bulkow LR; Negus SE; Spradling PR; Homan C; Drobeniuc J; Bruce M; Kamili S; Hu DJ; McMahon BJ
    Hepatology; 2012 Aug; 56(2):516-22. PubMed ID: 22371069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-Dose Universal Hepatitis A Immunization in Argentina: Low Viral Circulation and High Persistence of Protective Antibodies Up to 4 Years.
    Vizzotti C; González J; Rearte A; Urueña A; Pérez Carrega M; Calli R; Gentile A; Uboldi A; Ramonet M; Cañero-Velasco M; Diosque M
    J Pediatric Infect Dis Soc; 2015 Dec; 4(4):e62-7. PubMed ID: 26582885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effectiveness of two doses versus three doses of hepatitis A vaccine in human immunodeficiency virus-infected and -uninfected men who have sex with men.
    Tseng YT; Chang SY; Liu WC; Sun HY; Wu CH; Wu PY; Lu CL; Hung CC; Chang SC
    Hepatology; 2013 May; 57(5):1734-41. PubMed ID: 23258666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity and safety of an inactivated hepatitis A vaccine amongst Singaporeans.
    Guan R; Ng HS; Fock KM; Ho KY; Yap I; Kang JY; Chow WC; Chew CN; Ng C; Teo CJ
    Southeast Asian J Trop Med Public Health; 1995 Jun; 26(2):268-71. PubMed ID: 8629058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity and safety of the inactivated hepatitis A vaccine in children with juvenile idiopathic arthritis on methotrexate treatment: a matched case-control study.
    Maritsi DN; Coffin SE; Argyri I; Vartzelis G; Spyridis N; Tsolia MN
    Clin Exp Rheumatol; 2017; 35(4):711-715. PubMed ID: 28721859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy and safety of vaccination against hepatitis A and B in patients with chronic liver disease].
    de Artaza Varasa T; Sánchez Ruano JJ; García Vela A; Gómez Rodríguez R; Romero Gutiérrez M; de la Cruz Pérez G; Gómez Moreno AZ; Carrobles Jiménez JM
    Gastroenterol Hepatol; 2009; 32(7):483-8. PubMed ID: 19577338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunogenicity of vaccines against viral hepatitis A and B in the population above 40 years of age -- impact of risk factors].
    Chlíbek R; Smetana J; Sindelár R; Cecetková B; Prymula R; Kohl I
    Epidemiol Mikrobiol Imunol; 2007 Aug; 56(3):119-28. PubMed ID: 17900060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody persistence and immune memory in healthy adults following vaccination with a two-dose inactivated hepatitis A vaccine: long-term follow-up at 15 years.
    Van Herck K; Jacquet JM; Van Damme P
    J Med Virol; 2011 Nov; 83(11):1885-91. PubMed ID: 21915861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccine induced Hepatitis A and B protection in children at risk for cystic fibrosis associated liver disease.
    Shapiro AJ; Esther CR; Leigh MW; Dellon EP
    Vaccine; 2013 Jan; 31(6):906-11. PubMed ID: 23261047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity of hepatitis A vaccine in children with celiac disease.
    Sari S; Dalgic B; Basturk B; Gonen S; Soylemezoglu O
    J Pediatr Gastroenterol Nutr; 2011 Nov; 53(5):532-5. PubMed ID: 21587080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term persistence of antibodies induced by vaccination and safety follow-up, with the first combined vaccine against hepatitis A and B in children and adults.
    Van Damme P; Leroux-Roels G; Law B; Diaz-Mitoma F; Desombere I; Collard F; Tornieporth N; Van Herck K
    J Med Virol; 2001 Sep; 65(1):6-13. PubMed ID: 11505437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of HAV and HBV infections and vaccination rates in patients with autoimmune liver diseases.
    Wörns MA; Teufel A; Kanzler S; Shrestha A; Victor A; Otto G; Lohse AW; Galle PR; Höhler T
    Am J Gastroenterol; 2008 Jan; 103(1):138-46. PubMed ID: 17970833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Vaccination against viral hepatitis A and B in adults aged over 40 years--antibody persistence and immune memory].
    Chlibek R; Smetana J; Bostíková V; Splino M
    Epidemiol Mikrobiol Imunol; 2011 Sep; 60(3):99-108. PubMed ID: 22132651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.